Tag
9 articles
Learn how to work with laminin protein data using Python and bioinformatics tools to understand the structural basis of cell therapies.
Learn how to analyze RNA modifications using Python, simulating the technology behind STORM Therapeutics' RNA-modifying enzyme inhibitors.
Grammy-nominated artist Aloe Blacc is transitioning from music and activism to biotech, aiming to fundraise for a cancer drug platform targeting pancreatic cancer. His journey highlights the complexities of funding biotech ventures beyond philanthropy.
HexemBio raises $10.4M to develop a novel stem cell rejuvenation therapy targeting blood cancers through a Nature-published approach that recreates embryonic conditions.
This article explains how artificial intelligence (AI) is revolutionizing the pharmaceutical industry by helping scientists discover new medicines faster. It explores the concept of AI pharma and how a major tech company invested $400 million in a tiny AI startup developing new treatments.
Anthropic has acquired Coefficient Bio, a stealth biotech startup founded just eight months ago, in a $400 million all-stock deal. The acquisition brings in a team of fewer than 10 former Genentech researchers, signaling Anthropic's expansion into healthcare AI.
Dutch biotech Laigo Bio has raised €17 million in seed funding to advance its innovative SureTACs platform, which targets previously 'undruggable' membrane proteins through protein degradation.
Ysios Capital launches a €100 million fund, InceptionBio, to support early-stage biotech companies created from Spanish academic research.
German biotech Kupando has raised €10M to advance its innate immunity drug KUP101 into human clinical trials, targeting solid tumors and drug-resistant infections.
